Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 10.8 Form of Escrow Agreement
- 10.14 License Agreement, Effective August 31, 2018, Between Clene Nanomedicine, Inc. and 4LIFE Research, LLC
- 23.1 Consent of Friedman LLP
- 23.2 Consent of Pricewaterhousecoopers LLP
- 99.1 Consent of Robert Etherington to Be Named As a Director of Clene Inc
- 99.2 Consent of Shalom Jacobovitz to Be Named As a Director of Clene Inc
- 99.3 Consent of Alison Mosca to Be Named As a Director of Clene Inc
- 99.4 Consent of Jonathon Gay to Be Named As a Director of Clene Inc
- 99.5 Consent of David Matlin to Be Named As a Director of Clene Inc
- 99.6 Consent of John Stevens to Be Named As a Director of Clene Inc
- 99.7 Consent of Reed Wilcox to Be Named As a Director of Clene Inc
- 99.8 Consent of Chidozie Ugwumba to Be Named As a Director of Clene Inc
- 99.9 Form of Proxy Card
Associated filings
- 21 Dec 20 EFFECT Notice of effectiveness
- 18 Dec 20 424B3 Prospectus supplement
- 15 Dec 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 14 Dec 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 7 Dec 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
18 Nov 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 19 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
CLNN similar filings
Filing view
External links